Search - tctmd.com

Displaying 401 - 420 of 855

Sort: Relevancy | Date

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Shelley Wood

August 15, 2022

News Daily News

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

L.A. McKeown

August 10, 2022

News Daily News

HF Deaths on the Rise in Young Adults, US Data Show

L.A. McKeown

August 03, 2022

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Two More Pig-to-Human Cardiac Xenotransplants Help Answer Many Unknowns

Yael L. Maxwell

July 12, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Daily News

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Yael L. Maxwell

June 16, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Conference News ESC Heart Failure 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

Shelley Wood

May 22, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

Advertisement

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

What’s Going to Be Hot at ESC 2022?

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

HF Deaths on the Rise in Young Adults, US Data Show

Early LV Recovery After TAVI Points to Better 5-Year Survival

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Two More Pig-to-Human Cardiac Xenotransplants Help Answer Many Unknowns

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

July 2022 News Roundup

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

TCTMD’s Top 10 Most Popular Stories for May 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Speech-Recognition Tool May Predict Worsening Congestion in HF

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content